CommercialCoverageMedium impact
06.02.47f, Noninvasive Prenatal Screening for Fetal Aneuploidies Using Cell-Free Fetal DNA (Independence Administrators)
Independence Blue Cross·OB-GYN, Family Medicine·Medical Policy
Effective date
Dec 19, 2025
We identified it
Jun 19, 2026
Summary
Independence Administrators has reissued their policy on noninvasive prenatal screening for fetal aneuploidies using cell-free fetal DNA, effective December 19, 2025. This is a policy reissue that may contain updated coverage criteria, prior authorization requirements, or billing guidelines for prenatal genetic screening tests.
Action Required
By December 19, 2025: OB-GYN providers and billing staff must review the updated policy at the source URL to identify any changes to coverage criteria, prior authorization requirements, or billing guidelines for noninvasive prenatal screening tests. Update billing protocols and prior authorization workflows accordingly to ensure compliance with the reissued policy.